Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:
ABIOMED, Inc. : This developer and seller of medical deviceshas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED’s shares gained 18.7% over the last one month more than S&P 500’s gain of 13.6%. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
Genesco Inc. (GCO - Free Report) : This footwear and apparel retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.
Genesco Inc. Price and Consensus
Genesco’s shares gained 17.4% over the last one month. The company possesses a Momentum Score of A.
Genesco Inc. Price
Wynn Resorts, Limited (WYNN - Free Report) : This destination casino resorts operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.
Wynn Resorts, Limited Price and Consensus
Wynn Resorts’ shares gained 25.2% over the last one month. The company possesses a Momentum Score of A.
Wynn Resorts, Limited Price
ArcBest Corporation (ARCB - Free Report) : This provider of freight transportation services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
ArcBest Corporation Price and Consensus
ArcBest’s shares gained 20.3% over the last one month. The company possesses a Momentum Score of B.
ArcBest Corporation Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:
ABIOMED, Inc. : This developer and seller of medical deviceshas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED’s shares gained 18.7% over the last one month more than S&P 500’s gain of 13.6%. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
Genesco Inc. (GCO - Free Report) : This footwear and apparel retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.
Genesco Inc. Price and Consensus
Genesco’s shares gained 17.4% over the last one month. The company possesses a Momentum Score of A.
Genesco Inc. Price
Wynn Resorts, Limited (WYNN - Free Report) : This destination casino resorts operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.
Wynn Resorts, Limited Price and Consensus
Wynn Resorts’ shares gained 25.2% over the last one month. The company possesses a Momentum Score of A.
Wynn Resorts, Limited Price
ArcBest Corporation (ARCB - Free Report) : This provider of freight transportation services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
ArcBest Corporation Price and Consensus
ArcBest’s shares gained 20.3% over the last one month. The company possesses a Momentum Score of B.
ArcBest Corporation Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on WYNN - FREE
Get the latest research report on GCO - FREE
Get the latest research report on ARCB - FREE